Guardant health announces inducement grants under nasdaq listing rule 5635(c)(4)

Palo alto, calif.--(business wire)--guardant health, inc. (nasdaq: gh), a leading precision oncology company, today announced that on october 22, 2024, the compensation committee of guardant's board of directors approved the granting of restricted stock units (“rsus”) representing 233,603 shares of its common stock to 123 new non-executive employees and non-qualified stock option awards to purchase an aggregate of 50,349 shares of its common stock to three new non-executive employees with a gra.
NDAQ Ratings Summary
NDAQ Quant Ranking